ALT-803 in the treatment of non-muscle-invasive bladder cancer: Preclinical and clinical evidence and translational potential

Bladder cancer (BCa) is one of the most common malignant tumors that cause death. Approximately 75%–85% of BCa develop into non-muscle-invasive bladder cancer (NMIBC). Bacillus Calmette-Guérin (BCG) is the gold standard for avoiding cystectomy in the treatment of NMIBC. Unfortunately, up to 30% of p...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wujun, Liu, Ning, Yuan, Yang, Zhu, Meng, Hu, Xiaokun, Hu, Wenchao, Wang, Shuai, Wang, Chao, Huang, Binghuan, Xing, Dongming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684637/
https://www.ncbi.nlm.nih.gov/pubmed/36439125
http://dx.doi.org/10.3389/fimmu.2022.1040669

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684637/
https://www.ncbi.nlm.nih.gov/pubmed/36439125
http://dx.doi.org/10.3389/fimmu.2022.1040669

Ejemplares similares